Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial

Ordi-Ros Josep; Saez-Comet Luis; Perez-Conesa Mercedes; Vidal Xavier; Riera-Mestre Antoni; Castro-Salomo Antoni; Cuquet-Pedragosa Jordi; Ortiz-Santamaria Vera; Mauri-Plana Montserrat; Sole Cristina; Cortes-Hernandez Josefina

首页> 外文期刊>Annals of Internal Medicine >Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial

【24h】

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial

机译：罗昔巴汉与维生素K拮抗剂在抗磷脂综合征中进行随机的非易生性试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The potential role of new oral anticoagulants in antiphospholipid antibody syndrome (APS) remains uncertain.

机译：背景：新口腔抗凝血剂在抗磷脂抗体综合征（APS）中的潜在作用仍然不确定。

著录项

来源
《Annals of Internal Medicine》 |2019年第10期|共11页
作者
Ordi-Ros Josep; Saez-Comet Luis; Perez-Conesa Mercedes; Vidal Xavier; Riera-Mestre Antoni; Castro-Salomo Antoni; Cuquet-Pedragosa Jordi; Ortiz-Santamaria Vera; Mauri-Plana Montserrat; Sole Cristina; Cortes-Hernandez Josefina;
展开▼
作者单位

Vall dHebron Res Inst Barcelona Spain;

Miguel Servet Hosp Zaragoza Spain;

Miguel Servet Hosp Zaragoza Spain;

Vall dHebron Res Inst Barcelona Spain;

Bellvitge Univ Hosp IDIBELL Barcelona Spain;

St Joan de Reus Univ Hosp Reus Spain;

Granollers Univ Hosp Granollers Spain;

Granollers Univ Hosp Granollers Spain;

Mataro Hosp Mataro Spain;

Vall dHebron Res Inst Barcelona Spain;

Vall dHebron Res Inst Barcelona Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial [J] . Ordi-Ros Josep, Saez-Comet Luis, Perez-Conesa Mercedes, Annals of Internal Medicine . 2019,第10期

机译：罗昔巴汉与维生素K拮抗剂在抗磷脂综合征中进行随机的非易生性试验
2. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome [J] . Annals of Internal Medicine . 2019,第10期

机译：罗昔巴汉与维生素K拮抗剂在抗磷脂综合征
3. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial [J] . Pengo V., Banzato A., Bison E., Lupus . 2016,第3期

机译：利伐沙班与华法林在高危抗磷脂综合征患者中的疗效和安全性：利伐沙班抗磷脂综合症（TRAPS）试验的原理和设计
4. Curosurf versus survanta in the treatment of neonatal respiratory distress syndrome in preterm infants: results from a randomized, multicenter masked comparison trial. [C] . Acta pharmacologica sinica . 2002

机译：Curosurf vs survanta在早产儿新生儿呼吸窘迫综合征的治疗中：一项来自随机，多中心，掩盖比较试验的结果。
5. Role of vitamin D receptor and vitamin D binding protein restriction fragment length polymorphisms in determining dose response to vitamin D: A randomized double blind placebo controlled trial [D] . Sai, Adarsh. 2011

机译：维生素D受体和维生素D结合蛋白限制性片段长度多态性在确定对维生素D的剂量反应中的作用：一项随机双盲安慰剂对照试验
6. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome with or without SLE [O] . H Cohen, C J Doré, S Clawson, -1

机译：利伐沙班治疗抗磷脂综合征（RAPS）方案：利伐沙班与华法林在有或无SLE的血栓性抗磷脂综合征患者中进行的前瞻性随机对照II / III期临床试验
7. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial [O] . Cohen Hannah, Hunt Beverley J, Efthymiou Maria, 2016

机译：利伐沙班与华法林联用治疗伴或不伴系统性红斑狼疮（RAPS）的血栓性抗磷脂综合征患者：一项随机，对照，开放标签，2/3期的非劣效性试验

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial

摘要

著录项

相似文献

相关主题

期刊订阅